MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$652,520K
Net Income
-$28,364K
Net Profit Margin
-4.35%
EPS
-$0.25
Unit: Thousand (K) dollars
Revenue Breakdown
Performance Suite
Specialty Technology And Service...
Administrative Service
Cases
Revenue Breakdown
Medicare Customers
Medicaid Customers
Commercial And Other Customers
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenue
652,520
496,246
490,438*
479,533
Cost of revenue
571,684
412,472
677,496*
379,759
Selling, general and administrative expenses
68,831
72,818
74,665*
77,592
Depreciation and amortization expenses
21,566
21,555
45,717*
23,615
Loss on lease termination
0
0
-2,521*
1,230
(gain) loss on disposal of non-strategic assets
-
-
3,717*
-
Right-of-use asset impairment
-
-
0*
-
Goodwill impairment
-
-
99,500*
-
Change in fair value of contingent consideration
0
0
3,320*
-1,089
Operating expenses
662,081
506,845
899,501*
478,647
Operating loss
-9,561
-10,599
-409,063*
886
Interest income
703
1,014
1,118*
964
Interest expense
16,859
16,868
15,357*
16,475
Loss (gain) from equity method investees
-41
-11
-164*
156
Loss on extinguishment/repayment of debt
-
-
-4,776*
431
Loss on option exercise
0
0
-52,250*
0
Extinguishment of series a preferred stock and other refinancing fees
0
-
-7,500*
6,000
Change in tax receivables agreement liability
-
-
-804*
0
Other income (expense), net
109
742
182*
80
Loss before income taxes
-25,649
-25,722
-473,615*
-19,958
Provision for (benefit from) income taxes
2,715
910
-247*
906
Income (loss) before preferred dividends and accretion of series a preferred stock
-28,364
-26,632
-473,368*
-20,864
Dividends and accretion of series a preferred stock
0
0
-10,997*
6,066
Net loss attributable to common shareholders of evolent health, inc. - diluted
-28,364
-26,632
-462,371
-26,930
Basic EPS
-0.25
-0.24
-4.104
-0.24
Diluted EPS
-0.25
-0.24
-4.104
-0.24
Basic Average Shares
112,542,000
111,905,000
112,676,000
114,066,000
Diluted Average Shares
112,542,000
111,905,000
112,676,000
114,066,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
Net loss
attributable to common...
-$28,364K
(44.48%↑ Y/Y)
Income (loss) before
preferred dividends and...
-$28,364K
(-42.55%↓ Y/Y)
Loss before income
taxes
-$25,649K
(-23.78%↓ Y/Y)
Provision for (benefit
from) income taxes
$2,715K
(429.09%↑ Y/Y)
Interest income
$703K
(-35.15%↓ Y/Y)
Other income
(expense), net
$109K
(411.43%↑ Y/Y)
Performance Suite
$484,503K
(80.84%↑ Y/Y)
Specialty Technology And
Services Suite
$78,161K
(-3.98%↓ Y/Y)
Administrative Service
$47,989K
(-14.12%↓ Y/Y)
Cases
$41,867K
(6.99%↑ Y/Y)
Interest expense
$16,859K
(45.32%↑ Y/Y)
Operating loss
-$9,561K
(-716.48%↓ Y/Y)
Revenue
$652,520K
(46.86%↑ Y/Y)
Loss (gain) from
equity method...
-$41K
(-120.81%↓ Y/Y)
Operating expenses
$662,081K
(48.62%↑ Y/Y)
Cost of revenue
$571,684K
(66.21%↑ Y/Y)
Selling, general and
administrative expenses
$68,831K
(-8.48%↓ Y/Y)
Depreciation and
amortization expenses
$21,566K
(-6.81%↓ Y/Y)
Buy us a coffee
Evolent Health, Inc. (EVH)
Evolent Health, Inc. (EVH)